Fundraising Fox
PDX Pharmaceuticals
Portland, US · Oregon corporation · 1 known investors
Find your way into PDX Pharmaceuticals
Sign up to see every warm intro you have to PDX Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PDX Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PDX Pharmaceuticals develops mesoporous silica nanoparticle platforms to co-deliver drugs, siRNA, and immunotherapy for treating multiple cancers and skin diseases. The company works in collaboration with OHSU on targeted and combination immunotherapeutics.
Founders & leadership
WY
Wassana YantaseeCo-founder · President/CEOWassana Yantasee is Founder and CEO of PDX Pharmaceuticals and Professor of Biomedical Engineering at Oregon Health and Science University. She has developed mesoporous silica nanoparticle platforms for therapeutic delivery, supported by multiple publications and National Cancer Institute grants.
WN
Worapol NgamcherdtrakulCo-founder · Head of Research & COOWorapol Ngamcherdtrakul has over 15 years of research experience in nanomedicine, drug delivery, and cancer immunotherapy. As Head of Research and COO of PDX Pharmaceuticals, he oversees preclinical research and regulatory activities for the company's nanoparticle-based therapeutic candidates.
AH
Angela HultNamed on SEC filing
JG
Joe GrayNamed on SEC filing
Investors · 1
Also in the syndicate · 1
Kuni Foundation
Funding
SEC filings, press & company announcements$1.6M disclosed across 1 of 2 rounds · 2019–2021
- Undisclosed amountSeries AJan 2021
Kuni Foundation
Source ↗
▶$1.6MraisedNov 2019 · 2 investors · BiotechnologyRule 506(b)
▶$1.6MraisedNov 2019 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wassana YantaseeExecutive Officer, Director
- Angela HultDirector
- Joe GrayDirector
- Worapol NgamcherdtrakulExecutive Officer
- Offering amount
- $4M
- Amount sold
- $1.6M
- First sale
- Nov 2019
- Incorporated
- Corporation, Oregon
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Greater PortlandGreater Portland Inc is a regional public-private partnership across two states and seven counties that works to attract, create, and expand businesses while developing the regional workforce and driving economic growth in the Greater Portland metropolitan area.
Seran BioscienceSerán is a contract development and manufacturing organization (CDMO) that provides drug formulation, development, and manufacturing services to pharmaceutical companies. The company specializes in process engineering, scaleup, and commercial manufacturing of solid dosage forms and advanced pharmaceutical technologies.
Companies working in the same space as PDX Pharmaceuticals.
Frequently asked questions
- What does PDX Pharmaceuticals do?
- PDX Pharmaceuticals develops mesoporous silica nanoparticle platforms to co-deliver drugs, siRNA, and immunotherapy for treating multiple cancers and skin diseases. The company works in collaboration with OHSU on targeted and combination immunotherapeutics.
- Who founded PDX Pharmaceuticals?
- PDX Pharmaceuticals was founded by Wassana Yantasee, Worapol Ngamcherdtrakul.
- How much funding has PDX Pharmaceuticals raised?
- PDX Pharmaceuticals has disclosed $1.6M raised across 1 of its 2 known rounds.
- Where is PDX Pharmaceuticals headquartered?
- PDX Pharmaceuticals is headquartered in Portland, US.